63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2200057058	2022-07-01	2022-02-27	A Single-Arm Prospective Exploratory Clinical Study Of ZanubrutinibCombined With Rituximab In The Tr ...	A Single-Arm Prospective Exploratory Clinical Study Of ZanubrutinibCombined With Rituximab In The Tr ...	Primary Immune Thrombocytopenia	Therapy Group:Zanubrutinib(80 mg, 2 times/day, for a total of 12 weeks) combined with Rituximab(375 ...	The Second Affiliated Hospital of Kunming Medical University	NULL	Pending	18	70	Both	Therapy Group:23;	Phase 1	China
2	NCT05369377 (ClinicalTrials.gov)	June 1, 2022	6/5/2022	Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia	Zanubrutiniband Eltrombopag as Second-line Treatment for Patients With Immune Thrombocytopenia: a Mu ...	Immune Thrombocytopenia	Drug: Zanubrutinib;Drug: Eltrombopag	Peking University People's Hospital	Beijing Hospital;The Sixth Medical Center of PLA General Hospital;Beijing Aerospace General Hospital ...	Not yet recruiting	18 Years	70 Years	All	150	Phase 2	China

First Previous1Next Last